Health & Safety Industry Today
Drug-Device Combination Products Market to Reach USD 186.52 Billion by 2030, Driven by Growth in Self-Administered Formats
Introduction
The drug device combination products market has gained significant attention in recent years as healthcare systems, payers and manufacturers look for integrated therapeutic solutions that combine drugs and devices in a single platform. According to a recent report by Mordor Intelligence, The drug device combination products market stood at USD 140.7 billion in 2025 and is forecast to reach USD 186.52 billion by 2030, advancing at a 5.8% CAGR fda.gov., growing at a compound annual growth rate (CAGR) of 5.8 % between 2025 and 2030.
The drug-device combination products market is driven by rising chronic disease prevalence, growing demand for self-administered care, and favorable regulatory pathways. Key trends, market segments, leading players, and dominant regions are shaping its growth.
Key Trends
- Rapidly Ageing Population Boosting Uptake of Self-Administered Delivery Formats
- Growing Burden of Chronic Illnesses Driving Demand for Targeted Combination Therapies
- Breakthroughs in Minimally-Invasive & Smart Delivery Platforms
- US FDA’s Expedited Combo-Product Pathways Shortening Time-to-Market
- High Recall Rates Linked to Sterility / Dose Accuracy
- Multicentre Regulatory Compliance Adds Cost & Delays
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:
Market Segmentation
By Product:
- Drug-Eluting Stents
- Transdermal Patches
- Infusion Pumps
- Drug-Coated Balloons
- Inhalers
- Prefilled Syringes
- Wearable Injectors
- Autoinjectors
- Others
By Application:
- Cardiovascular Diseases
- Diabetes
- Cancer Therapy
- Respiratory Disorders
- Pain Management
- Others
By End-User
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Others
By Route of Administration
- Oral
- Parenteral
- Transdermal
- Implantable
- Others
Geography Analysis:
North America remains a key player in the drug-device combination products market, driven by strong regulatory support, significant healthcare investment, and strategic acquisitions that expand portfolios. Partnerships in digital health are fostering integrated monitoring systems, strengthening market presence.
Asia-Pacific is emerging rapidly, supported by cost-effective manufacturing, streamlined regulatory processes, and government-backed incentives. Regional contract manufacturers and favorable clinical-trial environments are enhancing global competitiveness..
Explore Our Full Library of Healthcare Research Industry Reports - https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=Industrytoday.co.uk
Key Players
Key players dominating the drug-device combination products market include Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Becton, Dickinson and Company, and Novartis AG, all of which leverage strong R&D capabilities, innovative product portfolios, and extensive global distribution networks to maintain their competitive edge in the rapidly growing healthcare sector.
Trending Reports
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking actionable market insights. With 550+ domain experts and specialists across 150+ countries, we deliver comprehensive syndicated and custom research across industries such as aerospace, agriculture, chemicals, consumer goods, energy, healthcare, and many more, helping organizations make informed decisions and achieve strategic goals.
For any inquiries or to access the full report, please contact:
https://www.mordorintelligence.com/
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
